Get my own profile
Public access
View all136 articles
23 articles
available
not available
Based on funding mandates
Co-authors
robert c. glenCambridge University and Imperial College LondonVerified email at cam.ac.uk
Jeremy L. JenkinsUS Head Chemical Biology & Therapeutics, Novartis Institutes for BioMedical ResearchVerified email at novartis.com
Isidro Cortés CirianoEMBL-EBIVerified email at ebi.ac.uk
Meir GlickDirector, Structural Chemistry, Merck & CoVerified email at merck.com
Prof. Gerard JP van WestenPI Computational Drug Discovery (Professor AI & Med Chem, Leiden University)Verified email at gjpvanwesten.nl
Julian FuchsBoehringer IngelheimVerified email at boehringer-ingelheim.com
Josef ScheiberManaging Director at BioVariance GmbHVerified email at josef-scheiber.de
Lewis MervinAstraZenecaVerified email at astrazeneca.com
Alexios KoutsoukasBristol Myers SquibbVerified email at bms.com
Herman van VlijmenHead, Computational ChemistryVerified email at its.jnj.com
Therese MalliavinUnite de Bioinformatique Structurale, CNRS/Institut PasteurVerified email at pasteur.fr
David R SpringUniversity of CambridgeVerified email at ch.cam.ac.uk
Jörg Kurt WegnerAssociate Scientific Director, Team Lead AI Design Team, Janssen R&D, Cambridge, MA, USVerified email at its.jnj.com
Eelke van der HorstThe HyveVerified email at thehyve.nl
Ola EngkvistAstraZeneca R&D Gothenburg Orcid:0000-0003-4970-6461Verified email at astrazeneca.com
Steven WhitebreadRetiredVerified email at one-name.org
Dr.Gautam SethiNational University of SingaporeVerified email at nus.edu.sg
Georgios DrakakisPost Doctoral Research AssociateVerified email at cam.ac.uk
Fredrik SvenssonCancer Research HorizonsVerified email at cancer.org.uk
Dezső MódosQuadram Institute BioscienceVerified email at quadram.ac.uk